South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 134, Issue 2, 2007, Pages 202-207

  Palep Singh, M ^a   Picton, H M ^b   Vrotsou, K ^c   Maruthini, D ^a   Balen, A H ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Caucasians; Gonadotropins; ICSI; IVF; Polycystic ovary syndrome (PCOS); South Asians

Indexed keywords

GONADOTROPIN;

ADULT; ARTICLE; ASIAN; BODY MASS; CAUCASIAN; CONTROLLED STUDY; EMBRYO TRANSFER; ETHNIC DIFFERENCE; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; SUBFERTILITY;

EID: 34748890081     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2007.02.005     Document Type: Article

References (32)

1. Balen A.H., Conway G.S., Kaltsas G., et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10 8 (1995) 2107-2111
2. Talbott E., Guzick D., Clerici A., et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15 7 (1995) 821-826
3. Michelmore K.F., Balen A.H., Dunger D.B., and Vessey M.P. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 51 6 (1999) 779-786
4. Polson D.W., Adams J., Wadsworth J., and Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1 8590 (1988) 870-872
5. Rodin D.A., Bano G., Bland J.M., Taylor K., and Nussey S.S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin Endocrinol (Oxf) 49 1 (1998) 91-99
6. Buyalos R.P., and Lee C.T. Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization. Fertil Steril 65 1 (1996) 1-10
7. Homburg R., Berkowitz D., Levy T., Feldberg D., Ashkenazi J., and Ben Rafael Z. In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 60 5 (1993) 858-863
8. Dor J., Shulman A., Levran D., Ben Rafael Z., Rudak E., and Mashiach S. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. Hum Reprod 5 7 (1990) 816-818
9. Homburg R., Levy T., Berkovitz D., et al. Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59 3 (1993) 527-531
10. Kodama H., Fukuda J., Karube H., Matsui T., Shimizu Y., and Tanaka T. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 10 8 (1995) 1962-1967
11. MacDougall M.J., Tan S.L., Balen A., and Jacobs H.S. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 8 2 (1993) 233-237
12. Urman B., Fluker M.R., Yuen B.H., Fleige-Zahradka B.G., Zouves C.G., and Moon Y.S. The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril 57 6 (1992) 1269-1273
13. Engmann L., Maconochie N., Sladkevicius P., Bekir J., Campbell S., and Tan S.L. The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology. Hum Reprod 14 1 (1999) 167-171
14. Jacobs H.S., and Agrawal R. Complications of ovarian stimulation. Baillieres Clin Obstet Gynaecol 12 4 (1998) 565-579
15. Ludwig M., Finas D.F., Al Hasani S., Diedrich K., and Ortmann O. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14 2 (1999) 354-358
16. Adams J., Polson D.W., Abdulwahid N., et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1985) 1375-1379
17. Balen A.H., Laven J.S., Tan S.L., and Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 6 (2003) 505-514
18. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Hum Reprod 2004;19(1):41-47.
19. Esmailzadeh S., Faramarzi M., and Jorsarai G. Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology. Eur J Obstet Gynecol Reprod Biol 121 1 (2005) 67-70
20. Webber L.J., Stubbs S., Stark J., et al. Formation and early development of follicles in the polycystic ovary. Lancet 362 9389 (2003) 1017-1021
21. Beloosesky R., Gold R., Almog B., et al. Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio. Int J Mol Med 14 2 (2004) 207-215
22. Hillier S.G., and Tetsuka M. Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol 11 2 (1997) 249-260
23. Weil S., Vendola K., Zhou J., and Bondy C.A. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84 8 (1999) 2951-2956
24. Wijeyaratne C.N., Balen A.H., Barth J.H., and Belchetz P.E. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?. Clin Endocrinol (Oxf) 57 3 (2002) 343-350
25. Aboulghar M.A., Mansour R.T., Serour G.I., Ramzy A.M., and Amin Y.M. Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 68 6 (1997) 1017-1021
26. Howles C.M., Macnamee M.C., Edwards R.G., Goswamy R., and Steptoe P.C. Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet 2 8505 (1986) 521-522
27. Lashen H., Ledger W., Bernal A.L., and Barlow D. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 14 3 (1999) 712-715
28. Fedorcsak P., Dale P.O., Storeng R., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 11 (2004) 2523-2528
29. Fedorcsak P., Dale P.O., Storeng R., Tanbo T., and Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 16 6 (2001) 1086-1091
30. Qublan H.S., Malkawi H.Y., Tahat Y.A., et al. In-vitro fertilisation treatment: factors affecting its results and outcome. J Obstet Gynaecol 25 7 (2005) 689-693
31. De L.V., La Marca A., Ditto A., Morgante G., and Cianci A. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72 2 (1999) 282-285
32. Yarali H., and Yildiz B. Metformin and FSH for induction of ovulation in women with polycystic ovary syndrome. Hum Reprod 17 11 (2002) 3007-3008